Company Filing History:
Years Active: 2024-2025
Title: Mirko Hennig: Innovator in Lipid Nanoparticle Technologies
Introduction
Mirko Hennig is a prominent inventor based in Mountain View, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of lipid nanoparticle compositions for therapeutic applications. With a total of 4 patents, Hennig's work focuses on innovative methods for delivering essential treatments to patients.
Latest Patents
Hennig's latest patents include groundbreaking technologies aimed at improving patient outcomes. One of his notable inventions is related to lipid nanoparticle compositions and their uses. This patent provides methods for delivering lipid nanoparticles (LNPs) to lung cells in subjects suffering from or at risk for primary ciliary dyskinesia (PCD). The method involves nebulizing a liquid pharmaceutical composition to create an aerosolized formulation for administration.
Another significant patent involves polynucleotide compositions and related formulations. This invention discloses compositions of polynucleotides that may encode for a cystic fibrosis transmembrane conductance regulator (CFTR) protein or its functional fragments. The polynucleotide can be combined with a lipid composition for targeted delivery to specific cells or organs, such as lung cells. The methods outlined in this patent aim to enhance the expression or activity of CFTR protein in cells and provide treatment options for conditions associated with CFTR deficiencies.
Career Highlights
Mirko Hennig is currently associated with Recode Therapeutics, Inc., where he continues to push the boundaries of innovation in biotechnology. His work has been instrumental in developing therapies that address critical health issues, particularly in respiratory conditions.
Collaborations
Hennig collaborates with talented professionals in his field, including Brandon A Wustman and Daniella Ishimaru. These collaborations enhance the research and development efforts at Recode Therapeutics, Inc., fostering an environment of innovation and discovery.
Conclusion
Mirko Hennig's contributions to lipid nanoparticle technologies and polynucleotide compositions represent significant advancements in the field of biotechnology. His innovative approaches have the potential to transform treatment options for patients with respiratory conditions and other related health issues.